Chakrapee-Sirisuk, SSinlarat, PLohsiriwat, DLert-Akayamanee, NNimmanwudipong, TSrimuninnimit, VVathanophas, VArch-Yaemsuan, PBoonnuch, W2009-05-272009-05-272001-08-05Chakrapee-Sirisuk S, Sinlarat P, Lohsiriwat D, Lert-Akayamanee N, Nimmanwudipong T, Srimuninnimit V, Vathanophas V, Arch-Yaemsuan P, Boonnuch W. Uracil with ftorafur and low dose oral folinic acid in advanced colorectal cancer. Journal of the Medical Association of Thailand. 2001 Aug; 84(8): 1142-7http://imsear.searo.who.int/handle/123456789/44816Chotmaihet Thangphaet.BACKGROUND: Low dose oral Folinic acid was used together with uracil with ftorafur (UFT) producing some response with low toxicity in advanced colorectal cancer. However, the 28 day regimen produced 20 per cent severe (grade III, IV) diarrhea. This study required 21 days' treatment to evaluate the response rate and toxicity in advanced colorectal cancer. METHOD: UFT 300 mg/m2/day together with oral Folinic acid 7.5 mg/dose for 21 days with 7 days rest were required to treat 28 cases of recurrent or metastatic colorectal cancer. RESULTS: Partial response was seen in 13.6 per cent of 22 evaluable cases and minimal response seen in 18.2 per cent. The majority (77%) of these patients had previously been treated with 5-fluorouracil (5-FU). These results are comparable to other studies. Toxicity was low with 3.3 per cent grade III, IV diarrhea. CONCLUSION: This regimen produced some activity in metastatic colorectal cancer with low toxicity.engAdministration, OralAdultAgedAntimetabolites, Antineoplastic --metabolismColorectal Neoplasms --drug therapyDiarrhea --chemically inducedDrug Administration ScheduleDrug SynergismDrug Therapy, CombinationFemaleHumansLeucovorin --metabolismMaleMiddle AgedNeoplasm Recurrence, Local --drug therapyNeoplasm StagingSeverity of Illness IndexTegafur --metabolismTime FactorsTreatment OutcomeUracil --metabolismClinical Trial